单位:[1]China Japan Friendship Hosp, Beijing, Peoples R China[2]Wuhan Union Hosp, Wuhan, Hubei, Peoples R China华中科技大学同济医学院附属协和医院[3]Manipal Hosp, Bangalore, Karnataka, India[4]Samsung Med Ctr, Seoul, South Korea[5]Seoul St Marys Hosp, Seoul, South Korea[6]Novo Nordisk Pharmaceut Ltd, Beijing, Peoples R China[7]Novo Nordisk Private Ltd, Bangalore, Karnataka, India[8]All India Inst Med Sci, New Delhi, India
第一作者单位:[1]China Japan Friendship Hosp, Beijing, Peoples R China
推荐引用方式(GB/T 7714):
Wenying Y.,Chen L.,Ji Q.,et al.Efficacy and safety of liraglutide compared with glimepiride, both combined with metformin, in an Asian population[J].DIABETOLOGIA.2010,53:
APA:
Wenying, Y.,Chen, L.,Ji, Q.,Bhattacharyya, A.,Kim, K. -W....&Tandon, N..(2010).Efficacy and safety of liraglutide compared with glimepiride, both combined with metformin, in an Asian population.DIABETOLOGIA,53,
MLA:
Wenying, Y.,et al."Efficacy and safety of liraglutide compared with glimepiride, both combined with metformin, in an Asian population".DIABETOLOGIA 53.(2010)